the Correlation Between Non-invasive Indicators in Patients With Biliary Atresia
Completed
- Conditions
- to Find Out Non-invasive Indices to Predict the Status of Hepatic Fibrosis in BA Patients.
- Registration Number
- NCT02848573
- Lead Sponsor
- National Taiwan University Hospital
- Brief Summary
we propose this study and try to find out possible clinical applicable non-invasive imaging indices or its combination with the laboratory indices to predict the status of hepatic fibrosis in BA patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 41
Inclusion Criteria
- pathological proved diagnosis of biliary atresia, and without other distinct abnormality or malformations. All had undergone Kasai portoenterostomy. All of them received abdominal MRI study.
Exclusion Criteria
- absence of laboratory data required.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pathologic METAVIR fibrosis score 1 month
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link hepatic fibrosis to biliary atresia progression in pediatric patients?
How do non-invasive imaging indices compare to liver biopsy in assessing fibrosis stages in biliary atresia?
Which biomarkers correlate with hepatic fibrotic scores in biliary atresia patients using ADC measurements?
What adverse events are associated with current non-invasive fibrosis monitoring strategies in biliary atresia?
Are there combination approaches of imaging and lab indices for predicting liver disease severity in biliary atresia?